SCHEMBL9890300

SCHEMBL9890300

c1ccc(-c2cc(-n3c4ccccc4c4ccccc43)c3oc4cc5c(cc4c3c2)oc2c(-n3c4ccccc4c4ccccc43)cc(-c3ccccc3)cc25)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 3/20 0.36
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
HSD17B10 Q99714 2/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
BRCA1 P38398 1/20 0.34
CYP3A4 P08684 3/20 0.32
HPGD P15428 3/20 0.32
HTR6 P50406 2/20 0.32
MAPT P10636 2/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
ALPI P09923 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
CASP3 P42574 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228705 0.92 PLA2G2A (0.42) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL24739518 0.91 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL9890118 0.89 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL17166658 0.87 PLA2G2A (0.39) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL9890359 0.85 KDM4E (0.35) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL13529143 0.85 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL14867871 0.85 PLA2G2A (0.37) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL14648687 0.84 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL24738469 0.84 TSHR (0.33) KDM4EL3MBTL1ATMALDH1A1KMT2A
SCHEMBL24738412 0.84 TSHR (0.33) KDM4EL3MBTL1ATMALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.